Skip to main content
Premium Trial:

Request an Annual Quote

Inventages, SAP to Build Personalized Medicine Firms

NEW YORK (GenomeWeb News) – Healthcare venture capital fund Inventages today said it is working with information technology company SAP to build new personalized medicine companies by integrating "a comprehensive and mechanism-based approach to disease management with best-in-class IT frameworks."

The collaboration aims to provide emerging healthcare companies with capital as well as expertise and resources by leveraging Inventages' experience in developing clinically validated products and SAP's expertise in building and operating IT platforms and ecosystems, the companies said.

While personalized medicine uses genetic and non-genetic information for disease diagnosis, treatment, and prevention, because of fragmented and incomplete information, the goals of truly personalized medicine have yet to be achieved, Inventages and SAP said. Their collaboration aims to take an approach to the field that incorporates genomic data, medical history, and environmental and lifestyle factors.

"This holistic approach to managing disease will require the integration of multiple data sources and the structuring and analysis of large data volumes," Inventages and SAP said in a statement. "This capability will be a key differentiator in ensuring the success and longevity of a personalized medicine solution."

"Inventages and SAP are aligned in their vision to advance personalized medicine through the use of information technology," Inventages Chairman and Managing Partner Gunnar Weikert added in the statement. "This collaboration plans to provide our companies with access to SAP's unique capabilities and resources in mobile, cloud, and big data processing."

Financial and other details of the collaboration were not disclosed.

Inventages is backed by Nestlé and focuses its investments on therapeutics and technologies with the potential to "radically improve the practice of medicine," it said. It has offices in London, Hong Kong, Auckland, NZ, and Nassau, Bahamas.

SAP develops enterprise software for business and customer management and is based in Walldorf, Germany.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.